Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Drug production value share of antineoplastics Japan 2018, by category

The statistic shows the distribution of the drug production value of antineoplastics in Japan in 2018, broken down by sub therapeutic category. In 2018, the production value of antimetabolites made up the largest share with approximately five percent of the total production value, followed by antitumor plant extract preparations with almost around 2.5 percent.

Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

August 2019

Region

Japan

Survey time period

2018

Supplementary notes

Antineoplastics are acting to prevent, inhibit or halt the development of a neoplasm (a tumor).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Japan "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.